Larsen syndrome
Larsen syndrome is a rare genetic disorder characterized by multiple joint dislocations, distinctive facial features, and other skeletal and developmental abnormalities. It was first described by Dr. Loren J. Larsen in 1950.
Presentation[edit | edit source]
Individuals with Larsen syndrome typically present with congenital joint dislocations, particularly affecting the knees, hips, and elbows. Other common features include:
- Flattened facial appearance
- Prominent forehead
- Depressed nasal bridge
- Wide-spaced eyes (hypertelorism)
- Cleft palate
- Short stature
- Spinal abnormalities, such as scoliosis or kyphosis
- Clubfoot (talipes equinovarus)
Genetics[edit | edit source]
Larsen syndrome is most commonly inherited in an autosomal dominant manner, although autosomal recessive forms have also been reported. Mutations in the FLNB gene, which encodes the protein filamin B, are responsible for the majority of cases. Filamin B plays a crucial role in the development and maintenance of the skeletal system.
Diagnosis[edit | edit source]
Diagnosis of Larsen syndrome is based on clinical evaluation, family history, and radiographic findings. Genetic testing can confirm the diagnosis by identifying mutations in the FLNB gene.
Management[edit | edit source]
Management of Larsen syndrome is multidisciplinary and may involve:
- Orthopedic interventions to address joint dislocations and spinal deformities
- Physical therapy to improve mobility and muscle strength
- Surgical correction of cleft palate and other craniofacial abnormalities
- Regular monitoring for potential complications, such as respiratory issues due to spinal deformities
Prognosis[edit | edit source]
The prognosis for individuals with Larsen syndrome varies depending on the severity of the condition and the presence of associated complications. With appropriate medical care and interventions, many individuals can lead relatively normal lives.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD